Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Hasegawa S et al. Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database. 2017 PLoS ONE pmid:28732067
McGlinchey EM et al. Prelimbic to Accumbens Core Pathway Is Recruited in a Dopamine-Dependent Manner to Drive Cued Reinstatement of Cocaine Seeking. 2016 J. Neurosci. pmid:27535915
Ganderton C et al. Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial. 2016 BMC Womens Health pmid:27312538
Brynhildsen J [Not Available]. 2016 Lakartidningen pmid:27299335
Liu X et al. Probing Steroidal Substrate Specificity of Cytochrome P450 BM3 Variants. 2016 Molecules pmid:27294908
Soliman AM et al. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy. 2016 J Manag Care Spec Pharm pmid:27123918
Hofmeyr GJ et al. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. 2016 Reprod Health pmid:27091008
Maybin JA and Critchley HO Medical management of heavy menstrual bleeding. 2016 Womens Health (Lond) pmid:26695687
Román M et al. Postmenopausal hormone therapy and the risk of breast cancer in Norway. 2016 Int. J. Cancer pmid:26289549
Cano-Nicolau J et al. Several synthetic progestins disrupt the glial cell specific-brain aromatase expression in developing zebra fish. 2016 Toxicol. Appl. Pharmacol. pmid:27245768
Fan F et al. Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. 2015 Toxicol. Sci. pmid:25752796
Callahan R et al. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review. 2015 Contraception pmid:26363431
Agarwal SK and Foster WG Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back. 2015 Biomed Res Int pmid:26247030
DiVasta AD et al. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial. 2015 Obstet Gynecol pmid:26181088
Noguchi LM et al. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. 2015 Lancet HIV pmid:26155597
Al Abdulhai SA et al. Bleeding and thrombosis in a patient with primary antiphospholipid syndrome using norethisterone: a case report. 2015 J Med Case Rep pmid:25895835
Lakryc EM et al. What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women? 2015 Clinics (Sao Paulo) pmid:25789519
Stachowiak G et al. Effect of transdermal hormone therapy on platelet haemostasis in menopausal women. 2015 Ann Agric Environ Med pmid:25780849
Morrison CS et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. 2015 PLoS Med. pmid:25612136
Zomerdijk IM et al. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study. 2015 BJOG pmid:25316196
Atrio J et al. The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception. 2015 Eur J Contracept Reprod Health Care pmid:25285572
DuBois BN et al. Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy. 2015 Contraception pmid:25245190
Posadzy-Malaczynska A et al. Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic. 2015 Clin Res Cardiol pmid:25216597
Jeffery J et al. Norethisterone interference in testosterone assays. 2014 Ann. Clin. Biochem. pmid:24265092
Crauwels HM et al. Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers. 2014 Int J Clin Pharmacol Ther pmid:24161160
Zhang X et al. Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis. 2014 Int J Clin Pharmacol Ther pmid:24161161
Reyes M et al. Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive. 2014 Eur. J. Clin. Pharmacol. pmid:24362488
Gusenleitner D et al. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action. 2014 PLoS ONE pmid:25058030
Huang R et al. Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway. 2014 Sci Rep pmid:25012808
Sweeney EE et al. Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study. 2014 Cancer Res. pmid:25304262
Polis CB et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. 2014 Contraception pmid:25183264
Borghese B et al. [Recurrence of pain after surgery for deeply infiltrating endometriosis: How does it happen? How to manage?]. 2014 J Gynecol Obstet Biol Reprod (Paris) pmid:23265672
Blanchard K et al. Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article. 2014 Contraception pmid:24924260
Freudenberger T et al. Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice. 2014 Br. J. Pharmacol. pmid:24923668
Govender Y et al. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. 2014 PLoS ONE pmid:24840644
Huijbregts RP et al. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. 2014 Contraception pmid:24674041
Atrio J et al. Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women. 2014 J. Acquir. Immune Defic. Syndr. pmid:24025339
Cooney R and Hayward P Highlights from the 21st CROI. 2014 Lancet Infect Dis pmid:24800301
Donnez J et al. Long-term treatment of uterine fibroids with ulipristal acetate ☆. 2014 Fertil. Steril. pmid:24630081
Caserta D et al. A 29-year-old woman with complex atypical hyperplasia and polycystic ovary syndrome: a challenging issue. 2014 Eur. J. Gynaecol. Oncol. pmid:24654474
Cates W Research on hormonal contraception and HIV. 2014 Lancet pmid:24461116
Gollub EL and Stein Z Research on hormonal contraception and HIV. 2014 Lancet pmid:24461117
Redd AD Research on hormonal contraception and HIV. 2014 Lancet pmid:24461118
Ralph L et al. Research on hormonal contraception and HIV - Authors' reply. 2014 Lancet pmid:24461119
Basavaraja N et al. Norethindrone-induced masculinization and progeny testing in guppy, Poecilia reticulata (Peters 1859). 2014 Indian J. Exp. Biol. pmid:24669666
Santos M et al. Retrospective review of norethindrone use in adolescents. 2014 J Pediatr Adolesc Gynecol pmid:24315714
Ferrero S et al. Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study. 2014 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:24388845
Kogan P and Wald M Male contraception: history and development. 2014 Urol. Clin. North Am. pmid:24286773
Labos G et al. Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23563111
Koskela-Niska V et al. Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study. 2013 Climacteric pmid:22640598
Brosnan JF et al. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture. 2013 Thromb. Res. pmid:22999413
Archer DF et al. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive. 2013 Obstet Gynecol pmid:23921878
Gutsche JT et al. Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy. 2013 J. Cardiothorac. Vasc. Anesth. pmid:24054188
Wistuba J et al. Experimental endocrine manipulation by contraceptive regimen in the male marmoset (Callithrix jacchus). 2013 Reproduction pmid:23431271
Tomasicchio M et al. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. 2013 PLoS ONE pmid:23658782
Polisseni AF et al. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. 2013 Maturitas pmid:23201326
Schneck H et al. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. 2013 Gynecol. Endocrinol. pmid:23116217
Połać I et al. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. 2013 Gynecol. Endocrinol. pmid:23116237
Chen FP et al. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. 2013 Taiwan J Obstet Gynecol pmid:24075375
Minami T et al. Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro. 2013 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:22964137
Crean CS et al. The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent. 2013 Int J Clin Pharmacol Ther pmid:24040852
Price T Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved? 2013 Menopause pmid:23511707
Stanczyk FZ and Winer SA Effect of hormone therapy on breast epithelial cell proliferation. 2013 Menopause pmid:23615638
Cheng G et al. Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. 2013 Menopause pmid:23615640
Neubauer H et al. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. 2013 Menopause pmid:23615641
Demeestere I et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. 2013 J. Clin. Oncol. pmid:23129737
Vercellini P et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. 2013 Hum. Reprod. pmid:23442755
Africander D et al. Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy. 2013 Biochem. Biophys. Res. Commun. pmid:23473756
Ralph LJ et al. Next steps for research on hormonal contraception and HIV. 2013 Lancet pmid:23810224
Zhou J et al. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. 2013 Maturitas pmid:23856385
Roach RE et al. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. 2013 J. Thromb. Haemost. pmid:23136837
Juvkam KH and Gudim HB [Drug induced displacement of menstruation]. 2013 Tidsskr. Nor. Laegeforen. pmid:23344601
Buccellato E et al. Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 2013 Expert Opin Drug Saf pmid:23701188
Manassiev N et al. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism. 2013 Clin. Endocrinol. (Oxf) pmid:22775481
Merviel P et al. [Interest of selective progesterone receptor modulators in endometriosis]. 2013 Gynecol Obstet Fertil pmid:23972920
Abdul-Hadi RA et al. The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria. 2013 Afr J Reprod Health pmid:24069754
Fels H et al. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives. 2013 Contraception pmid:23352800
Polis CB and Curtis KM Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. 2013 Lancet Infect Dis pmid:23871397
Biddle ST et al. Metabolism of norethisterone in the greyhound. 2013 Rapid Commun. Mass Spectrom. pmid:24019188
Ferrero S et al. Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. 2013 Arch. Gynecol. Obstet. pmid:23053314
Mackay L et al. Hormone replacement therapy for women with type 1 diabetes mellitus. 2013 Cochrane Database Syst Rev pmid:23744560
LoRusso PM et al. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. 2013 Cancer Chemother. Pharmacol. pmid:23064958
Jonusiene G et al. Sexual function, mood and menopause symptoms in Lithuanian postmenopausal women. 2013 Climacteric pmid:22845491
Adeyemi AS and Adekanle DA Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria. 2012 Jan-Mar Ann Afr Med pmid:22199044
Naqaish T et al. Patient satisfaction for levonorgestrel intrauterine system and norethisterone for treatment of dysfunctional uterine bleeding. 2012 Jan-Mar J Ayub Med Coll Abbottabad pmid:23855088
Rea V et al. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies. 2012 Biochemistry pmid:22208729
Dahm AE et al. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. 2012 Thromb. Res. pmid:22217510
Lopes I et al. Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium. 2012 Ecotoxicology pmid:22314390
Vercellini P et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. 2012 Hum. Reprod. pmid:22926841
Morrison CS et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. 2012 AIDS pmid:22156973
Queenan JT Exploring contraceptive options for breastfeeding mothers. 2012 Obstet Gynecol pmid:22183205
Kaore SN et al. Novel actions of progesterone: what we know today and what will be the scenario in the future? 2012 J. Pharm. Pharmacol. pmid:22775208
Chawla B et al. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani. 2012 PLoS ONE pmid:22438895
Castilho CS et al. Genetic structure and conservation of Mountain Lions in the South-Brazilian Atlantic Rain Forest. 2012 Genet. Mol. Biol. pmid:22481876
Kumar V et al. Bioremediation of agro-based pulp mill effluent by microbial consortium comprising autochthonous bacteria. 2012 ScientificWorldJournal pmid:22448126
Gümüş BA and Neubert E New taxa of terrestrial molluscs from Turkey (Gastropoda, Pristilomatidae, Enidae, Hygromiidae, Helicidae). 2012 Zookeys pmid:22423194
Chen X et al. Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery. 2012 Int J Nanomedicine pmid:22412300
Tenne SJ and Schwaneberg U First insights on organic cosolvent effects on FhuA wildtype and FhuA Δ1-159. 2012 Int J Mol Sci pmid:22408464
Puli MR and Raghavendra AS Pyrabactin, an ABA agonist, induced stomatal closure and changes in signalling components of guard cells in abaxial epidermis of Pisum sativum. 2012 J. Exp. Bot. pmid:22131162
Kraut R et al. Fluorescence correlation methods for imaging cellular behavior of sphingolipid-interacting probes. 2012 Methods Cell Biol. pmid:22325612